| In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers CM Lehr, JA Bouwstra, EH Schacht, HE Junginger International journal of Pharmaceutics 78 (1-3), 43-48, 1992 | 1349 | 1992 |
| Diverse applications of nanomedicine B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves, AM Andrews, S Ashraf, ... ACS nano 11 (3), 2313-2381, 2017 | 1301 | 2017 |
| Towards the sustainable discovery and development of new antibiotics M Miethke, M Pieroni, T Weber, M Brönstrup, P Hammann, L Halby, ... Nature Reviews Chemistry 5 (10), 726-749, 2021 | 733 | 2021 |
| Preparation and characterization of cationic PLGA nanospheres as DNA carriers MNVR Kumar, U Bakowsky, CM Lehr Biomaterials 25 (10), 1771-1777, 2004 | 713 | 2004 |
| Nanoparticles–an efficient carrier for drug delivery into the hair follicles J Lademann, H Richter, A Teichmann, N Otberg, U Blume-Peytavi, ... European Journal of Pharmaceutics and Biopharmaceutics 66 (2), 159-164, 2007 | 691 | 2007 |
| Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa A Lamprecht, U Schäfer, CM Lehr Pharmaceutical research 18, 788-793, 2001 | 627 | 2001 |
| Lectin-mediated drug targeting: history and applications C Bies, CM Lehr, JF Woodley Advanced drug delivery reviews 56 (4), 425-435, 2004 | 592 | 2004 |
| Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease ALF Lamprecht, N Ubrich, H Yamamoto, U Schäfer, H Takeuchi, ... Journal of Pharmacology and Experimental Therapeutics 299 (2), 775-781, 2001 | 529 | 2001 |
| The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro G Borchard, HL Lueβen, AG de Boer, JC Verhoef, CM Lehr, HE Junginger Journal of controlled release 39 (2-3), 131-138, 1996 | 520 | 1996 |
| A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro C Kneuer, M Sameti, U Bakowsky, T Schiestel, H Schirra, H Schmidt, ... Bioconjugate Chemistry 11 (6), 926-932, 2000 | 460 | 2000 |
| Lectin-mediated drug delivery:: The second generation of bioadhesives CM Lehr Journal of Controlled Release 65 (1-2), 19-29, 2000 | 448 | 2000 |
| The human epidermis models EpiSkin®, SkinEthic® and EpiDerm®: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance … F Netzlaff, CM Lehr, PW Wertz, UF Schaefer European Journal of Pharmaceutics and Biopharmaceutics 60 (2), 167-178, 2005 | 434 | 2005 |
| Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA C Kneuer, M Sameti, EG Haltner, T Schiestel, H Schirra, H Schmidt, ... International journal of pharmaceutics 196 (2), 257-261, 2000 | 418 | 2000 |
| Selective follicular targeting by modification of the particle sizes A Patzelt, H Richter, F Knorr, U Schäfer, CM Lehr, L Dähne, W Sterry, ... Journal of controlled release 150 (1), 45-48, 2011 | 368 | 2011 |
| Nanoparticle geometry and surface orientation influence mode of cellular uptake H Herd, N Daum, AT Jones, H Huwer, H Ghandehari, CM Lehr ACS nano 7 (3), 1961-1973, 2013 | 351 | 2013 |
| Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides N Nafee, S Taetz, M Schneider, UF Schaefer, CM Lehr Nanomedicine: Nanotechnology, Biology and Medicine 3 (3), 173-183, 2007 | 346 | 2007 |
| Nanoparticles made from novel starch derivatives for transdermal drug delivery MJ Santander-Ortega, T Stauner, B Loretz, JL Ortega-Vinuesa, ... Journal of controlled release 141 (1), 85-92, 2010 | 343 | 2010 |
| Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity EM Collnot, C Baldes, MF Wempe, R Kappl, J Hüttermann, JA Hyatt, ... Molecular pharmaceutics 4 (3), 465-474, 2007 | 330 | 2007 |
| Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges CA Ruge, J Kirch, CM Lehr The lancet Respiratory medicine 1 (5), 402-413, 2013 | 301 | 2013 |
| Mucus as a barrier to lipophilic drugs HH Sigurdsson, J Kirch, CM Lehr International journal of pharmaceutics 453 (1), 56-64, 2013 | 300 | 2013 |
Marc SchneiderProfessor for Biopharmaceutics and Pharmaceutical Technology, Saarland UniversityBestätigte E-Mail-Adresse bei mx.uni-saarland.de
